Compare HBIO & NOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBIO | NOMA |
|---|---|---|
| Founded | 1901 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Services-Misc. Amusement & Recreation |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 29.3M |
| IPO Year | 2000 | 2025 |
| Metric | HBIO | NOMA |
|---|---|---|
| Price | $8.13 | $1.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.8K | ★ 22.9K |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,176,000.00 | $6,376.00 |
| Revenue This Year | $3.76 | N/A |
| Revenue Next Year | $5.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $1.31 |
| 52 Week High | $8.40 | $10.00 |
| Indicator | HBIO | NOMA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.35 |
| Support Level | N/A | $1.31 |
| Resistance Level | N/A | $2.47 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 0.00 | 68.25 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Nomadar Corp operates at the intersection of sports and technology, focusing on high-performance training programs and cultural exchange. The company aims to connect athletes, coaches, and fans through inventive technological solutions, enhancing sports development beyond physical borders. It offers services like the High Performance Training (HPT) program and promotes the legacy of iconic athletes. The Company generates revenue through its High Performance Training Program and events management at the JP Financial Stadium.